Quant Memo

Paper Explained

When a Beautiful Backtest Is a Mirage: The Deflated Sharpe Ratio

The 2014 paper explaining why a stunning backtest is usually a statistical illusion, and how to discount it once you admit how many strategies you tried.

QM
Quant Memo

July 6, 2026

The paper

The Deflated Sharpe Ratio: Correcting for Selection Bias, Backtest Overfitting, and Non-Normality

David H. Bailey and Marcos López de Prado · 2014

Here's a trick that should worry you. Take a coin, a perfectly fair one, and give one to each of a thousand people. Have everyone flip ten times. By pure luck, a few people will flip nine or ten heads. Now put the best flipper on stage, show the audience their incredible streak, and announce you've discovered a person with a magical gift for flipping heads.

It's obviously nonsense. With a thousand triers, someone was always going to get a hot streak by chance alone. The streak says nothing about skill.

Trading strategy backtests have exactly this disease, and it's the whole subject of this paper. Bailey and López de Prado's message is blunt and important: a great-looking backtest is usually not a discovery, it's the luckiest coin-flipper on stage. And they give you a way to see through the illusion.

The number everyone brags about

When someone shows off a trading strategy, they almost always lead with its Sharpe ratio. You don't need the formula, just the meaning: the Sharpe ratio measures how much return you got for the amount of bumpiness you endured. High Sharpe = smooth, steady gains. Low Sharpe = a wild, stomach-churning ride for the same reward. It's the single most common scorecard in the industry.

A backtest that shows a high Sharpe looks like gold. The strategy would have made great, steady money on historical data. Surely that means it's good?

Not so fast.

The rot at the center: you didn't try just one thing

Here's the dirty secret of strategy research. Nobody builds one strategy, tests it once, and ships it. They try hundreds or thousands of variations. Should the moving average be 10 days or 50? Buy on Mondays or Fridays? Add this filter, tweak that threshold, exclude that year? Each tweak gets backtested, and the researcher keeps the version with the prettiest results.

That's the coin-flip trick in disguise. Test enough strategies on the same historical data and some will look spectacular by pure luck, they just happened to line up with the random wiggles of the past. When you then parade the best one, you're putting the luckiest coin-flipper on stage and calling it skill.

This is called backtest overfitting, and the two authors showed something genuinely alarming: with enough tries, you can produce an impressive-looking backtest out of pure noise, every single time. The strategy has learned the historical data's random quirks by heart, quirks that will never repeat, so it dazzles on the past and collapses the moment it meets fresh, live data.

The core insight: a high score means less when you took many shots

The fix starts with a simple, fair-minded question: how impressive is this Sharpe ratio, given how many strategies were tried to find it?

A Sharpe ratio of 2 from testing a single well-reasoned idea is genuinely exciting. The exact same Sharpe of 2, cherry-picked as the best of 10,000 random tweaks, is completely unremarkable, you'd expect a "winner" that good to pop up by luck alone. Same number, wildly different meaning, and the difference is how many shots you took.

This is the same logic as a familiar warning in science: if you run enough experiments, some will look "significant" purely by chance, so you must set a higher bar when you've tested many things. Bailey and López de Prado brought that discipline to trading.

What "deflating" the Sharpe actually does

Their tool, the Deflated Sharpe Ratio, takes your shiny backtest number and marks it down to account for the whole hidden search behind it. In plain terms, it adjusts for:

  • How many strategies you tried. The more variations you tested, the higher the bar the winner must clear to count as real, because a lucky winner was more likely to appear.
  • How long the track record is. A great result over 3 years is far flimsier than the same result over 30 years. Short samples are easy to luck into.
  • How lumpy the returns were. Real trading returns aren't tidy. They have fat tails and nasty surprises, and a strategy whose "steady" record leans on a few freak lucky months deserves extra suspicion.

Feed those in, and instead of "wow, Sharpe of 2!" you get an honest answer to the real question: once we account for all the shots taken, is there any believable evidence of genuine skill here, or is this just the best of a thousand coin-flips? Often, the deflated number quietly reveals the "amazing" strategy is worthless.

Why this landed so hard

This paper (and the related work the same authors did on backtest overfitting) hit a nerve because it named a pervasive, uncomfortable industry sin:

  • It exposed a firehose of false discoveries. A staggering share of published strategies and pitched funds are overfit mirages. This work gave people a principled reason, and a tool, to be skeptical.
  • It shifted the burden of proof. After this, "look at my beautiful backtest" stopped being enough. The right response became: how many strategies did you try to find this one? That question alone deflates most hype.
  • It connected trading to real statistics. The multiple-testing problem was well understood in medicine and science. Bailey and López de Prado dragged quant finance into the same rigor, insisting that trying many things demands a higher bar.

The honest limitations

The tool is a discipline, not a magic filter:

  • You have to be honest about your trial count. The whole correction hinges on knowing how many strategies were really tested, and researchers are famously bad at counting, or admitting, all the tweaks they quietly tried. Lowball that number and you fool the tool along with yourself.
  • It tells you what's fake, not what's real. A deflated Sharpe that survives the discount is less likely to be a fluke, but "survived" is not "proven." It's a stronger filter, not a guarantee of future profit.
  • Prevention beats detection. The deeper cure isn't a fancy adjustment after the fact; it's not overfitting in the first place, using out-of-sample testing, walk-forward validation, and plain restraint in how much you tinker.
  • It leans on statistical assumptions. Like any formula, it can be gamed or misapplied. It's a sanity check to respect, not an oracle to worship.

The one-line takeaway

Bailey and López de Prado gave a name and a remedy to finance's most seductive lie: a gorgeous backtest is usually just the luckiest coin-flipper on stage, and once you honestly account for how many strategies you tried, most "amazing" results deflate into noise.

Related concepts